Bharat Biotech International Ltd
- India
DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation…
Read More » - Technology
Role of CSIR-IICT in the Synthesis of Agonist molecule for use in COVAXIN developed by Bharat Biotech International Ltd.
The unforeseen COVID-19 pandemic has brought along several challenges to the healthcare sector and many CSIR constituent laboratories have been…
Read More »